Evidence Suggests The Spinal Muscular Atrophy Gene Therapy Could Help all Patients Regardless of Severity

According to a story from BNN Bloomberg, data from three studies suggest that Zolgensma, a gene therapy for spinal muscular atrophy developed by Novartis, could be useful to all patients…

Continue Reading Evidence Suggests The Spinal Muscular Atrophy Gene Therapy Could Help all Patients Regardless of Severity
Cognitive Bias in Idiopathic Pulmonary Fibrosis Management and Steps We Can Take to Avoid It
Source: Pixabay.com

Cognitive Bias in Idiopathic Pulmonary Fibrosis Management and Steps We Can Take to Avoid It

Cedric Rutland, a pulmonologist at Pacific Pulmonary Medical Group has shared his experience, research, and thoughts on cognitive bias in an effort to spread awareness for the issue, and hopefully,…

Continue Reading Cognitive Bias in Idiopathic Pulmonary Fibrosis Management and Steps We Can Take to Avoid It

First Ever Treatment for Transthyretin-Mediated Amyloidosis Cardiomyopathy Approved by FDA

Transthyretin-Mediated Amyloidosis Cardiomyopathy The FDA has just approved the very first treatment for hereditary or wild-type transthyretin-mediated amyloidosis cardiomyopathy (ATTR-CM).  ATTR-CM is a rare disease that occurs when amyloids, an…

Continue Reading First Ever Treatment for Transthyretin-Mediated Amyloidosis Cardiomyopathy Approved by FDA

Rare Alabama’s Rare Disease Advocacy Day

  • Post author:
  • Post category:

Rare Disease Advocacy Day May 8th, 2019 Are you a patient from Alabama? Well this is your opportunity to speak with lawmakers directly about your concerns and what you think…

Continue Reading Rare Alabama’s Rare Disease Advocacy Day
New Data on the Difference Between Plasma Cell Myeloma and Smoldering Myeloma Has Treatment Implications
ColiN00B / Pixabay

New Data on the Difference Between Plasma Cell Myeloma and Smoldering Myeloma Has Treatment Implications

A recent report that was published in the Swiss Medical Weekly outlines data gathered by a Swiss panel of experts on plasma cell myeloma. The report offers an update and…

Continue Reading New Data on the Difference Between Plasma Cell Myeloma and Smoldering Myeloma Has Treatment Implications

Drink One For Dane: Dutch Bros Coffee Hosts 13th Annual Amyotrophic Lateral Sclerosis Fundraiser This Friday, May 10th

Dutch Bros Coffee is hosting their 13th annual fundraiser for amyotrophic lateral sclerosis (ALS) this Friday, May 10th, 2019. It's called "Drink One for Dane" in honor of Dane Boersma,…

Continue Reading Drink One For Dane: Dutch Bros Coffee Hosts 13th Annual Amyotrophic Lateral Sclerosis Fundraiser This Friday, May 10th

Finding an Effective Personalized Therapy for Mastocytosis can be Frustrating, but it is Possible

What Exactly is Mast Cell Disease According to The Mastocytosis Society (TMS), there are three forms of mast cell disease. All involve the malfunction or over-development of mast cells in…

Continue Reading Finding an Effective Personalized Therapy for Mastocytosis can be Frustrating, but it is Possible
Despite Loss of Speaking Ability, This Amyotrophic Lateral Sclerosis Patient Testified to Congress in Support of Medicare for All
skeeze / Pixabay

Despite Loss of Speaking Ability, This Amyotrophic Lateral Sclerosis Patient Testified to Congress in Support of Medicare for All

According to a story from The Intercept, Ady Barkan's life is slowly slipping away as his amyotrophic lateral sclerosis continues to progress. Despite this, Ady has developed a reputation as…

Continue Reading Despite Loss of Speaking Ability, This Amyotrophic Lateral Sclerosis Patient Testified to Congress in Support of Medicare for All

The LLS Ground-Breaking Precision Medicine Approach Master Trial  BEAT AML Releases Third Year Test Results

  A recent posting by the Leukemia and Lymphoma Society references the Beat AML Master Trial. The trial evaluates targeted therapies to treat acute myeloid leukemia (AML) and was launched…

Continue Reading The LLS Ground-Breaking Precision Medicine Approach Master Trial  BEAT AML Releases Third Year Test Results

Sisters with Multiple Sclerosis Share Their Scary Stevens-Johnson Syndrome Story In an Effort to Spread Awareness

An Unexpected Emergency Kristin Hardy and her sister Margaret are no strangers to rare disease. Kristin has primary progressive multiple sclerosis (MS) and Margaret has relapsing-remitting multiple sclerosis. Margaret also…

Continue Reading Sisters with Multiple Sclerosis Share Their Scary Stevens-Johnson Syndrome Story In an Effort to Spread Awareness

87 Businesses Across Two Countries Displayed a Purple Light for Sarcoidosis Awareness Last Month

Sarcoidosis Sarcoidosis is a rare inflammatory condition that causes granulomas to buildup within the organs. These can cause permanent organ damage. While the condition can affect various organs, and presents…

Continue Reading 87 Businesses Across Two Countries Displayed a Purple Light for Sarcoidosis Awareness Last Month